- Management of dyslipidemia during reproductive years
- What a cardiologist needs to know about menopause transition and HRT in 2026
- Cardiovascular Health in Women with Pregnancy Related Risk Enhancers: Putting Evidence into Action
- Non obstructive CAD in women: microvascular disease & more
- SCAD in Asia Pacific Region
|
- Management of dyslipidemia during reproductive years
- What a cardiologist needs to know about menopause transition and HRT in 2026
- Cardiovascular Health in Women with Pregnancy Related Risk Enhancers: Putting Evidence into Action
- Non obstructive CAD in women: microvascular disease & more
- SCAD in Asia Pacific Region
|
Novel biomarkers and therapies in dyslipidemia
|
Novel biomarkers and therapies in dyslipidemia
|
- Targeting Lipoprotein (a): emerging therapies and clinical trial updates
- Calcium score and plaque density - a novel assessment tool
- Can AI augment traditional risk calculators for personalized therapy?
- PCSK9 Inhibitors and Beyond: Inclisiran, Oral Agents, and the Next Wave of Innovation
- Updates on hypertriglyceridemia management
|
- Targeting Lipoprotein (a): emerging therapies and clinical trial updates
- Calcium score and plaque density - a novel assessment tool
- Can AI augment traditional risk calculators for personalized therapy?
- PCSK9 Inhibitors and Beyond: Inclisiran, Oral Agents, and the Next Wave of Innovation
- Updates on hypertriglyceridemia management
|
Cardiovascular-kidney-metabolic syndrome
|
Cardiovascular-kidney-metabolic syndrome
|
- Defining the CKM syndrome
- MRA in CKM prevention
- Role of SGLT-2 inhibtitors in prevention
- Role of GLPra in CVD prevention
- Beyond DCM syndrome: what is new?
|
- Defining the CKM syndrome
- MRA in CKM prevention
- Role of SGLT-2 inhibtitors in prevention
- Role of GLPra in CVD prevention
- Beyond DCM syndrome: what is new?
|
Obesity and the Heart: A Multifaceted Approach to Cardiovascular Health
|
Obesity and the Heart: A Multifaceted Approach to Cardiovascular Health
|
- Obesity-Related Cardiometabolic Syndrome: A Deeper Dive into Pathophysiology and Clinical Management
- Beyond the BMI: Novel Biomarkers and Imaging Techniques for Cardiovascular Risk Stratification in Obese Patients
- Bariatric and Metabolic Surgery: A Paradigm Shift in Managing Severe Obesity and Its Cardiovascular Complications
- Pharmacological Innovations in Obesity Management: From GLP-1 Agonists to Next-Generation Therapeutics
- Childhood Obesity and the Lifelong Cardiovascular Health Trajectory: Prevention and Early Intervention Strategies
|
- Obesity-Related Cardiometabolic Syndrome: A Deeper Dive into Pathophysiology and Clinical Management
- Beyond the BMI: Novel Biomarkers and Imaging Techniques for Cardiovascular Risk Stratification in Obese Patients
- Bariatric and Metabolic Surgery: A Paradigm Shift in Managing Severe Obesity and Its Cardiovascular Complications
- Pharmacological Innovations in Obesity Management: From GLP-1 Agonists to Next-Generation Therapeutics
- Childhood Obesity and the Lifelong Cardiovascular Health Trajectory: Prevention and Early Intervention Strategies
|
When Blood Meets Heart: Uniting Hematology and Cardiology in Multiple Myeloma and AL Amyloidosis Care
|
When Blood Meets Heart: Uniting Hematology and Cardiology in Multiple Myeloma and AL Amyloidosis Care
|
- When should we suspect infiltrative cardiac disease?
- From Hematology Perspective: Myeloma to AL Amyloidosis
Plasma Cell Disorders Unveiled: From Multiple Myeloma to AL Amyloidosis – Mechanisms, Clinical Profiles, and Emerging Therapies
- From Cardiology Perspective: The Infiltrated and Injured Heart
The Infiltrated Heart: Recognizing and Managing AL Cardiac Amyloidosis
- From Cardiology Perspective: The Infiltrated and Injured Heart
AL Cardiac Amyloidosis in Taiwan: Epidemiology, Dignostic Trends, and Clinical Insights
- From Cardiology Perspective: The Infiltrated and Injured Heart
Guarding the Heart: Cardiovascular Considerations in Modern Myeloma and AL Amyloidosis Therapy
|
- When should we suspect infiltrative cardiac disease?
- From Hematology Perspective: Myeloma to AL Amyloidosis
Plasma Cell Disorders Unveiled: From Multiple Myeloma to AL Amyloidosis – Mechanisms, Clinical Profiles, and Emerging Therapies
- From Cardiology Perspective: The Infiltrated and Injured Heart
The Infiltrated Heart: Recognizing and Managing AL Cardiac Amyloidosis
- From Cardiology Perspective: The Infiltrated and Injured Heart
AL Cardiac Amyloidosis in Taiwan: Epidemiology, Dignostic Trends, and Clinical Insights
- From Cardiology Perspective: The Infiltrated and Injured Heart
Guarding the Heart: Cardiovascular Considerations in Modern Myeloma and AL Amyloidosis Therapy
|
ACS Guidelines: Perspectives from Asia Pacific
|
ACS Guidelines: Perspectives from Asia Pacific
|
- AI-Assisted ECG Interpretation and Pre hospital Cath Lab Activation: Enhancing STEMI Pathways in Taiwan’s 2026 Guidelines
- Personalized Antithrombotic Therapy: Integrating Japanese Pharmacogenomic and Dose‑Response Insights into ACS Guidelines
- KAMIR‑Driven Guideline Development: Harnessing Real‑World Registry Data to Inform Korea’s ACS Recommendations
- Bridging the Gap: Tailoring ACS Care for Remote Regions and First Nations Peoples in the 2025 Australian Guidelines
- 2026 Taiwan ACS Guideline Update: Role of Multi-Modality Approach in the Identification and Assessment of MINOCA
|
- AI-Assisted ECG Interpretation and Pre hospital Cath Lab Activation: Enhancing STEMI Pathways in Taiwan’s 2026 Guidelines
- Personalized Antithrombotic Therapy: Integrating Japanese Pharmacogenomic and Dose‑Response Insights into ACS Guidelines
- KAMIR‑Driven Guideline Development: Harnessing Real‑World Registry Data to Inform Korea’s ACS Recommendations
- Bridging the Gap: Tailoring ACS Care for Remote Regions and First Nations Peoples in the 2025 Australian Guidelines
- 2026 Taiwan ACS Guideline Update: Role of Multi-Modality Approach in the Identification and Assessment of MINOCA
|
Atrial Fibrillation & Hypertension Guidelines: Asian-Pacific Perspectives
|
Atrial Fibrillation & Hypertension Guidelines: Asian-Pacific Perspectives
|
- Take at a glance of 2025 Taiwan AF guidelines
- What's new in the Hypertension Guideline?
- Assessment of Blood pressure in patients with AF
- What's new in the Hypertension Guideline?
- Management of Hypertension in specific populations
|
- Take at a glance of 2025 Taiwan AF guidelines
- What's new in the Hypertension Guideline?
- Assessment of Blood pressure in patients with AF
- What's new in the Hypertension Guideline?
- Management of Hypertension in specific populations
|
IHD: Frontiers in diagnosis and therapy
|
IHD: Frontiers in diagnosis and therapy
|
- Timing of Complete Revascularization in STEMI patients with multiple vessel disease, where do we stand in 2025?
- Revascularization Strategies for Left Main Disease: PCI versus CABG in the Asia-Pacific Context
- IntraVascular imaging in PCI: Universal Adoption or Selective Use in regional settings
- Future Potential Important Pharmacological Therapy in ACS
- ANOCA, INOCA, and MINOCA: Demystification and Emerging Perspectives
|
- Timing of Complete Revascularization in STEMI patients with multiple vessel disease, where do we stand in 2025?
- Revascularization Strategies for Left Main Disease: PCI versus CABG in the Asia-Pacific Context
- IntraVascular imaging in PCI: Universal Adoption or Selective Use in regional settings
- Future Potential Important Pharmacological Therapy in ACS
- ANOCA, INOCA, and MINOCA: Demystification and Emerging Perspectives
|
IHD: Unresolved Challenges
|
IHD: Unresolved Challenges
|
- Asymptomatic Multivessel Disease With LV Systolic Dysfunction: Revascularize or Not, and How Best to Do It
- PCI in Patients With Cardiogenic Shock: Optimal Device Choice and Timing
- Drug-Coated Balloon: Promise, Hype, or Reality
- DAPT Duration After PCI: How Short Can We Go
- Tackling Inflammation: A New Frontier in Ischemic Heart Disease in Asian Pacific
|
- Asymptomatic Multivessel Disease With LV Systolic Dysfunction: Revascularize or Not, and How Best to Do It
- PCI in Patients With Cardiogenic Shock: Optimal Device Choice and Timing
- Drug-Coated Balloon: Promise, Hype, or Reality
- DAPT Duration After PCI: How Short Can We Go
- Tackling Inflammation: A New Frontier in Ischemic Heart Disease in Asian Pacific
|
- Artificial Intelligence for Myocardial Perfusion Imaging and Risk Prediction in PCI Decision Making
- AI for Early Detection of Myocardial Infarction: From ECG to Multimodal Integration
- From Wire-Based FFR to AI-Based Angiophysiology: What’s Real, What’s Hype?
- AI and Intravascular Imaging: From Automated Analysis to Precision PCI
- AI and Health-Care Models for Ischemic Heart Disease: From Prehospital Acute Care to Community Chronic Care
|
- Artificial Intelligence for Myocardial Perfusion Imaging and Risk Prediction in PCI Decision Making
- AI for Early Detection of Myocardial Infarction: From ECG to Multimodal Integration
- From Wire-Based FFR to AI-Based Angiophysiology: What’s Real, What’s Hype?
- AI and Intravascular Imaging: From Automated Analysis to Precision PCI
- AI and Health-Care Models for Ischemic Heart Disease: From Prehospital Acute Care to Community Chronic Care
|
Aortic valve disease in Asia
|
Aortic valve disease in Asia
|
- Bicuspid aortic stenosis in Asia: Prevalence and pathophysiology
- Treatment of Bicuspid AS: When TAVI? When SAVR?
- Challenges in small annulus TAVR: Strategies and device selection
- Aortic regurgitation: TAVI new kid in the block
- Redo-TAVR: simplifying workup for procedural success
|
- Bicuspid aortic stenosis in Asia: Prevalence and pathophysiology
- Treatment of Bicuspid AS: When TAVI? When SAVR?
- Challenges in small annulus TAVR: Strategies and device selection
- Aortic regurgitation: TAVI new kid in the block
- Redo-TAVR: simplifying workup for procedural success
|
Structural interventions for mitral valve disease
|
Structural interventions for mitral valve disease
|
- Primary vs secondary mitral regurgitation: Understanding the differences
- Practical guide to selecting the right patients for mitral TEER
- Latest updates on mitral TEER devices
- Valve-in-Valve and Valve-in-Ring Mitral Replacement: Practical Pearls and Pitfalls
- TMVR for Native Mitral Disease: Emerging Devices, Challenges, and Future Directions
|
- Primary vs secondary mitral regurgitation: Understanding the differences
- Practical guide to selecting the right patients for mitral TEER
- Latest updates on mitral TEER devices
- Valve-in-Valve and Valve-in-Ring Mitral Replacement: Practical Pearls and Pitfalls
- TMVR for Native Mitral Disease: Emerging Devices, Challenges, and Future Directions
|
Tricuspid Transcatheter Intervention: From Patient Selection to Next-Gen Devices
|
Tricuspid Transcatheter Intervention: From Patient Selection to Next-Gen Devices
|
- Multivalvular Disease & the Tricuspid Valve - Assessment and Management Strategies
- Repair or Replace? - Latest Insights in Transcatheter TR Therapy
- Predictors of Success in TEER- Is There a Perfect Risk Tool?
- Mastering TEER in Challenging Anatomy - Technical Tips an Imaging Guidance
- Tricuspid Hotline 2025-New Devices and Future Directions
|
- Multivalvular Disease & the Tricuspid Valve - Assessment and Management Strategies
- Repair or Replace? - Latest Insights in Transcatheter TR Therapy
- Predictors of Success in TEER- Is There a Perfect Risk Tool?
- Mastering TEER in Challenging Anatomy - Technical Tips an Imaging Guidance
- Tricuspid Hotline 2025-New Devices and Future Directions
|
Optimizing Post-cardiac Arrest Care after Resuscitation from Sudden Cardiac Arrest
|
Optimizing Post-cardiac Arrest Care after Resuscitation from Sudden Cardiac Arrest
|
- Optimizing Post-cardiac Arrest Care in the Critical Early Post-resuscitation Phase
- Primary or Early Coronary Catheterization with or without Intervention in Patients with Cardiac Arrest - Who and When?
- Optimal Pharmacological and/or Mechanical Support for Hemodynamically or Electrically Unstable Patients in the Early Post-cardiac Arrest Phase
- Infection Control and Metabolic/Nutritional Support in Post-Cardiac Arrest Care
- Updates in Target Temperature Management, Prognostic Evaluation, and Rehabilitation/Recovery
|
- Optimizing Post-cardiac Arrest Care in the Critical Early Post-resuscitation Phase
- Primary or Early Coronary Catheterization with or without Intervention in Patients with Cardiac Arrest - Who and When?
- Optimal Pharmacological and/or Mechanical Support for Hemodynamically or Electrically Unstable Patients in the Early Post-cardiac Arrest Phase
- Infection Control and Metabolic/Nutritional Support in Post-Cardiac Arrest Care
- Updates in Target Temperature Management, Prognostic Evaluation, and Rehabilitation/Recovery
|
Potpurri in Cardiac Surgery
|
Potpurri in Cardiac Surgery
|
- MIS Valve Surgery in Taiwan: State of the Art
- Aortic Aneurysm Surgery: Is the a Role for Open Surgery Anymore?
- Surgery For Chronic Pulmonary Embolism
- Mechanical Circulatory Support: Current Status
- Heart Transplantation in Taiwan
|
- MIS Valve Surgery in Taiwan: State of the Art
- Aortic Aneurysm Surgery: Is the a Role for Open Surgery Anymore?
- Surgery For Chronic Pulmonary Embolism
- Mechanical Circulatory Support: Current Status
- Heart Transplantation in Taiwan
|
Controversies in Cardiac Surgery
|
Controversies in Cardiac Surgery
|
- The Great Debate: SAVR vs TAVR (proTAVR)
- The Great Debate: SAVR vs TAVR (proSAVR)
- The Great Debate: Isolated TR should be treated Surgically
- The Great Debate: Isolated TR should be treated Percutaneously
|
- The Great Debate: SAVR vs TAVR (proTAVR)
- The Great Debate: SAVR vs TAVR (proSAVR)
- The Great Debate: Isolated TR should be treated Surgically
- The Great Debate: Isolated TR should be treated Percutaneously
|
Clinical Conundrums in Advanced Heart Failure
|
Clinical Conundrums in Advanced Heart Failure
|
- Guideline Directed Medical Therapy Post-LVAD & Transplantation - Evidence to Cease & Desist?
- Recent updates on Inotropes, Vasopressors & Vasodilators
- Predicting & Preventing Worsening Heart Failure - Unattainable Reality?
- Screening & Managing Sarcopenia & Frailty in Advanced Heart Failure
- Palliative Care in Advanced Heart Failure - Not Just End-of-Life Care
|
- Guideline Directed Medical Therapy Post-LVAD & Transplantation - Evidence to Cease & Desist?
- Recent updates on Inotropes, Vasopressors & Vasodilators
- Predicting & Preventing Worsening Heart Failure - Unattainable Reality?
- Screening & Managing Sarcopenia & Frailty in Advanced Heart Failure
- Palliative Care in Advanced Heart Failure - Not Just End-of-Life Care
|
Landscape of Cardio-Oncology in Asia Pacific
|
Landscape of Cardio-Oncology in Asia Pacific
|
- Cancer Therapy Related Cardiac Dysfunction 101: Focus on Anthracyclines & Transtuzumab
- Immune Checkpoint Inhibitors & Myocarditis - Current Standard of Care
- Understanding & Implementing Permissive Cardiotoxicity
- Tools I Use to Predict & Prevent Cardiotoxicity - From SUCCOUR to Statins
- Cardiovascular Concerns & Considerations After Cancer Therapy - Survivorship & Beyond
|
- Cancer Therapy Related Cardiac Dysfunction 101: Focus on Anthracyclines & Transtuzumab
- Immune Checkpoint Inhibitors & Myocarditis - Current Standard of Care
- Understanding & Implementing Permissive Cardiotoxicity
- Tools I Use to Predict & Prevent Cardiotoxicity - From SUCCOUR to Statins
- Cardiovascular Concerns & Considerations After Cancer Therapy - Survivorship & Beyond
|
Comorbidities & Heart Failure Crosstalk
|
Comorbidities & Heart Failure Crosstalk
|
- Iron Repletion in Heart Failure - Are Current Trials Enough to Support Widespread Use?
- Diagnostic & Therapeutic Gaps in Heart Failure & COPD
- The Skinny on Obesity & Heart Failure
- Atrial Fibrillation & HFpEF - Two Sides of the Same Coin?
|
- Iron Repletion in Heart Failure - Are Current Trials Enough to Support Widespread Use?
- Diagnostic & Therapeutic Gaps in Heart Failure & COPD
- The Skinny on Obesity & Heart Failure
- Atrial Fibrillation & HFpEF - Two Sides of the Same Coin?
|
State-of-the-Art Cardiac Ablation
|
State-of-the-Art Cardiac Ablation
|
- Integrating Multimodality Imaging Techniques for Enhanced Guidance in VT Ablation Procedures
- Management of Atrial Fibrillation in Heart Failure Patients: Integrated Care Approaches
- Combined AF ablation and LAAO implantation - is it a paradigm shift for AF management?
- Should PFA replace thermal energy for all AF ablation?
- Pulsed Field Ablation for Ventricular Tachycardia: Translating Atrial Innovation to the Ventricles
|
- Integrating Multimodality Imaging Techniques for Enhanced Guidance in VT Ablation Procedures
- Management of Atrial Fibrillation in Heart Failure Patients: Integrated Care Approaches
- Combined AF ablation and LAAO implantation - is it a paradigm shift for AF management?
- Should PFA replace thermal energy for all AF ablation?
- Pulsed Field Ablation for Ventricular Tachycardia: Translating Atrial Innovation to the Ventricles
|
Innovations in Cardiac Pacing and Device Therapy
|
Innovations in Cardiac Pacing and Device Therapy
|
- Physiological Pacing in Heart Failure: CRT vs conduction system pacing
- Leadless Pacemakers: Current Status and Future Directions
- Subcutaneous ICD and Extravascular ICD - should we offer as first line in all ICD patients?
- Making sense of subclinical AF detection in wearables
- Subclinical AF detection in implantable devices- should we anticoagulate
|
- Physiological Pacing in Heart Failure: CRT vs conduction system pacing
- Leadless Pacemakers: Current Status and Future Directions
- Subcutaneous ICD and Extravascular ICD - should we offer as first line in all ICD patients?
- Making sense of subclinical AF detection in wearables
- Subclinical AF detection in implantable devices- should we anticoagulate
|
Advanced Concepts in Arrhythmia
|
Advanced Concepts in Arrhythmia
|
- Cascade Screening in Sudden Cardiac Death
- Arrhythmia in Pregnancy: Identifying High-Risk Features for Sudden Cardiac Death
- Updates in Sudden Cardiac Death Prevention and Management in Hypertrophic Cardiomyopathy
- AI-Driven Identification of Patients Eligible for Primary Prevention with Implantable Cardioverter-Defibrillators
- Artificial Intelligence and Machine Learning in Arrhythmia Prediction and Management
|
- Cascade Screening in Sudden Cardiac Death
- Arrhythmia in Pregnancy: Identifying High-Risk Features for Sudden Cardiac Death
- Updates in Sudden Cardiac Death Prevention and Management in Hypertrophic Cardiomyopathy
- AI-Driven Identification of Patients Eligible for Primary Prevention with Implantable Cardioverter-Defibrillators
- Artificial Intelligence and Machine Learning in Arrhythmia Prediction and Management
|
Updates in Management of Hypertension
|
Updates in Management of Hypertension
|
- Seven action approaches for the management of hypertension in Asia – The HOPE Asia network
- The Clinical Application of Time in therapeutic Range in the management of hypertension
- Which BP cut-off should I follow - deciding between the ESH, ESC or AHA Guidelines
- AI in Blood Pressure Management - The Way Forward in Asia Pacific
- Hypertension Management in the Elderly - How Low Do We Go?
|
- Seven action approaches for the management of hypertension in Asia – The HOPE Asia network
- The Clinical Application of Time in therapeutic Range in the management of hypertension
- Which BP cut-off should I follow - deciding between the ESH, ESC or AHA Guidelines
- AI in Blood Pressure Management - The Way Forward in Asia Pacific
- Hypertension Management in the Elderly - How Low Do We Go?
|
Resistant Hypertension and Complex Circumstances
|
Resistant Hypertension and Complex Circumstances
|
- Secondary Hypertension - Where Do I Start?
- Hypertension in Pregnancy
- Resistant Hypertension in CKD
- Aldosterone Synthase Inhibitors in Resistant Hypertension
- Controversies in renal denervation therapy evidence
|
- Secondary Hypertension - Where Do I Start?
- Hypertension in Pregnancy
- Resistant Hypertension in CKD
- Aldosterone Synthase Inhibitors in Resistant Hypertension
- Controversies in renal denervation therapy evidence
|
Echoing the Essentials: Guideline-based must-knows in the use of echocardiography for cardiac imaging
|
Echoing the Essentials: Guideline-based must-knows in the use of echocardiography for cardiac imaging
|
- Deep Dive into Diastology: navigating the latest guidelines
- Leveraging Left Atrial Strain: Technique and Clinical Applications
- Deconstructing the Mitral valve: interrogation of the mitral valve in structural heart interventions
- Adding value to Aortic Imaging: Refined assessment of aortic valve diseases and aortopathies
- Echo Imaging in Guiding Tricuspid Valve Intervention
|
- Deep Dive into Diastology: navigating the latest guidelines
- Leveraging Left Atrial Strain: Technique and Clinical Applications
- Deconstructing the Mitral valve: interrogation of the mitral valve in structural heart interventions
- Adding value to Aortic Imaging: Refined assessment of aortic valve diseases and aortopathies
- Echo Imaging in Guiding Tricuspid Valve Intervention
|
Multi-modality imaging of the right heart
|
Multi-modality imaging of the right heart
|
- The Right Stuff: Current standards for the echocardiographic assessment of right ventricle
- Right Under Pressure: How I Use Multimodality Imaging When Managing Pulmonary Hypertension
- Right on time: Cardiac POCUS for prompt echocardiographic assessment of the right ventricle in cardiopulmonary disease (e.g. pulmonary embolism)
- Right on Track: Imaging the right ventricle in grown-up congenital heart diseases
- Ramping up the Imaging: Incremental benefit of CMR for right heart cardiomyopathies
|
- The Right Stuff: Current standards for the echocardiographic assessment of right ventricle
- Right Under Pressure: How I Use Multimodality Imaging When Managing Pulmonary Hypertension
- Right on time: Cardiac POCUS for prompt echocardiographic assessment of the right ventricle in cardiopulmonary disease (e.g. pulmonary embolism)
- Right on Track: Imaging the right ventricle in grown-up congenital heart diseases
- Ramping up the Imaging: Incremental benefit of CMR for right heart cardiomyopathies
|
Echoing AI: Advances in imaging through echocardiography powered by artificial intelligence
|
Echoing AI: Advances in imaging through echocardiography powered by artificial intelligence
|
- REVIEW: Current and emerging AI applications in echocardiography across the globe
- REVEAL: Uncovering subclinical heart diseases using AI-powered echocardiography
- REFINE: AI-assisted Echocardiographic Evaluation of Heart Failure and Cardiomyopathies
- REVIVE: AI prediction of ventricular remodeling in heart diseases
- REGULATE: Standards and safeguards for ethics, research and resource implications for AI integration in echo labs in Asia
|
- REVIEW: Current and emerging AI applications in echocardiography across the globe
- REVEAL: Uncovering subclinical heart diseases using AI-powered echocardiography
- REFINE: AI-assisted Echocardiographic Evaluation of Heart Failure and Cardiomyopathies
- REVIVE: AI prediction of ventricular remodeling in heart diseases
- REGULATE: Standards and safeguards for ethics, research and resource implications for AI integration in echo labs in Asia
|
A New Spectrum in Adult Congenital Heart Disease Management
|
A New Spectrum in Adult Congenital Heart Disease Management
|
- Transition of Care from Paediatric to Adult Congenital Heart Disease Services: Challenges and Solutions
- Advanced Imaging in Adult Congenital Heart Disease: Guiding Diagnosis and Intervention.
- Arrhythmia Management in Adults with Congenital Heart Disease: From Prevention to Intervention
- Cardiovascular shunt intervention in adult with congenital heart disease
- Pregnancy and Delivery in Women with Congenital Heart Disease: Risk Stratification and Management Strategies
|
- Transition of Care from Paediatric to Adult Congenital Heart Disease Services: Challenges and Solutions
- Advanced Imaging in Adult Congenital Heart Disease: Guiding Diagnosis and Intervention.
- Arrhythmia Management in Adults with Congenital Heart Disease: From Prevention to Intervention
- Cardiovascular shunt intervention in adult with congenital heart disease
- Pregnancy and Delivery in Women with Congenital Heart Disease: Risk Stratification and Management Strategies
|
Tetralogy of Fallot: StatPearls
|
Tetralogy of Fallot: StatPearls
|
- The Burden of TOF among Asia Pacific population
- The Masked Population of Late Presenter Tetralogy of Fallot: Do you Dare to do RVOT stent the Patient?
- When to decide re intervention after Tetralogy of Fallot Repair
- Percutaneous Pulmonary Valve Replacement : A review of current valve technology
- Navigating arrhythmia in Tetralogy of Fallot
|
- The Burden of TOF among Asia Pacific population
- The Masked Population of Late Presenter Tetralogy of Fallot: Do you Dare to do RVOT stent the Patient?
- When to decide re intervention after Tetralogy of Fallot Repair
- Percutaneous Pulmonary Valve Replacement : A review of current valve technology
- Navigating arrhythmia in Tetralogy of Fallot
|
The evolving landscape of pulmonary hypertension:
New Horizon across Groups Pulmonary Hypertension
|
The evolving landscape of pulmonary hypertension:
New Horizon across Groups Pulmonary Hypertension
|
- Recent progress and innovation in group 1 pulmonary artery hypertension
- Pulmonary Hypertension in Pediatric and Adult Congenital Heart Disease: Challenges, Disparities and opportunities.
- Pulmonary hypertension caused by left-side heart disease: challenge and future perspective
- Therapies for PH in ILD and COPD: Hope on the Horizon?
- From Inoperable to Treatable: BPA Revolution in CTEPH
|
- Recent progress and innovation in group 1 pulmonary artery hypertension
- Pulmonary Hypertension in Pediatric and Adult Congenital Heart Disease: Challenges, Disparities and opportunities.
- Pulmonary hypertension caused by left-side heart disease: challenge and future perspective
- Therapies for PH in ILD and COPD: Hope on the Horizon?
- From Inoperable to Treatable: BPA Revolution in CTEPH
|
Heart Failure: Novel mechanisms & innovative treatment
|
Heart Failure: Novel mechanisms & innovative treatment
|
- Genomic analysis in HF
- Omics analysis in HF
- Diabetes, metabolism, HF
- Gene & Cell tharapy for heart failure using concept of transdifferentiation of fibroblst to cardiomyocytes
- iPSC cell therapy for heart failure
|
- Genomic analysis in HF
- Omics analysis in HF
- Diabetes, metabolism, HF
- Gene & Cell tharapy for heart failure using concept of transdifferentiation of fibroblst to cardiomyocytes
- iPSC cell therapy for heart failure
|
Vascular Biology: What's new?
|
Vascular Biology: What's new?
|
- Vascular endothelium in health and disease
- The Role of Activator Protein-1 Complex in Diabetes-Associated Atherosclerosis: Insights From Single-Cell RNA Sequencing
- Mechanistic exploration on fluorescent gold nanoclusters for ABCA1 induction to prevent high pressure induced coronary vulnerable plaque rupture
- Roles of CHIP in vascular diseases
- From Elastic Fiber Integrity to Compensatory Collagen Deposition: PPARγ and CD248 in Aneurysm Disease
|
- Vascular endothelium in health and disease
- The Role of Activator Protein-1 Complex in Diabetes-Associated Atherosclerosis: Insights From Single-Cell RNA Sequencing
- Mechanistic exploration on fluorescent gold nanoclusters for ABCA1 induction to prevent high pressure induced coronary vulnerable plaque rupture
- Roles of CHIP in vascular diseases
- From Elastic Fiber Integrity to Compensatory Collagen Deposition: PPARγ and CD248 in Aneurysm Disease
|
|
|
|
|